December 2008 Corrections Page

Corrections and Clarifications

TSC Staff

12/11/08 - 12:23 PM EST

An article originally published Dec. 10, Elan's Martin Named Worst Biotech CEO of '08, incorrectly stated that Louis Bucalo is the chief executive of Titan Pharmaceuticals (TTP:Amex). In fact, Marc Rubin has been Titan's president and CEO since October 2007. Prior to that time, Bucalo held the titles of CEO, president and chairman. Bucalo continued to serve as chairman until April 2008, when he left the board of directors. TheStreet.com regrets the error. (Corrected Dec. 11.)

Visit TheStreet for more great features

TheStreet Premium Services

From the action-oriented investing ideas of Action Alerts PLUS by Jim Cramer to the expert technical trading strategies of Helene Meisler's Top Stocks, TheStreet.com offers a range of premium services to help boost your portfolio's performance. View now.

Expert Advisors Alerts Delivered to your Inbox

Action Alerts PLUS: Cramer's personal portfolio, emails before he acts.

RealMoney: 70+ experts share their top investing ideas and analysis.

Stocks Under $10: Alerts identify undervalued stocks with profit potential.

FREE NEWSLETTERS

Get an edge on the market with the help of free email newsletters like Jim Cramer's Daily Booyah!. Learn about the day's major market events, companies that sizzled or fizzled and lots more that can help you make more profitable investing decisions. Sign up.